Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Trump lashes out at Crockett, renews call for...
Trump goes after Zelenskyy over ‘land swapping’ dispute,...
Democratic whistleblower told FBI that Adam Schiff approved...
MORNING GLORY: Trump meets Putin amid an era...
‘Things need to change’: Senate Democrats sharpen criticism...
Mamdani zings Cuomo in rent-stabilized housing spat during...
Unearthed emails reveal White House nixed Biden visiting...
Strong drilling targets identified next to high-grade gold-copper...
Seymour Lithium Project Achieves Permitting Milestone
Acquisition of Silver Extraction Technology
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Business

Lawmakers ask Mark Zuckerberg to show how Facebook, Instagram are addressing illicit drug ads

by admin August 17, 2024
August 17, 2024
Lawmakers ask Mark Zuckerberg to show how Facebook, Instagram are addressing illicit drug ads

A bipartisan group of lawmakers sent Meta CEO Mark Zuckerberg a letter on Thursday expressing concern that the company is failing to prevent illicit drug advertisements from running on its platform.

The House members cited recent reports from The Wall Street Journal and nonprofit Tech Transparency Project, which uncovered a flood of ads on Facebook and Instagram that pointed users to third-party services where they could purchase prescription pills, cocaine and other recreational drugs.

“On March 16, 2024, the Wall Street Journal reported that U.S. federal prosecutors have been investigating Meta for facilitating the sale of illicit drugs,” the lawmakers wrote. “Instead of quickly addressing the issue and fully removing the illicit content, on July 31, 2024, the Wall Street Journal again reported that Meta was ‘“running ads on Facebook and Instagram that steer users to online marketplaces for illegal drugs.’”

Most troubling, they wrote, is that Meta continues to run ads despite the company facing an investigation by U.S. federal prosecutors “for facilitating the sale of illicit drugs.”

The letter’s 19 authors include Reps. Tim Walberg (R-Mich.), Gus Bilirakis (R-Fla.), Kathy Castor (D-Fla.) and Lori Trahan (D-Mass.). They noted that the illicit drug ads were “approved and monetized by Meta” and that they were not hidden on the dark web or private social media pages. Media outlets and researchers could easily find the ads, which contained “contained blatant references to illegal drugs,” while Meta’s internal processes apparently missed them.

“Time and time again we have heard from Meta that users come to your platforms because they like the personalization and experiences you provide, and you use sensitive personal information to direct such personalization through content and advertisements,” the lawmakers wrote. “We in Congress, on multiple occasions, have worked to establish data privacy and security protections for Americans but have, in each instance, been met with friction and opposition from Meta with claims that we would drastically disrupt this personalization you are providing.”

They sent Zuckerberg a list of 15 questions intended to uncover more details about how Meta is addressing the problem, and asked him to respond by Sept. 6.

Meta confirmed receipt of the letter and said it plans to respond. The company shared with CNBC the same statement it gave the Journal for its initial story.

“Drug dealers are criminals who work across platforms and communities, which is why we work with law enforcement to help combat this activity. Our systems are designed to proactively detect and enforce against violating content, and we reject hundreds of thousands of ads for violating our drug policies. We continue to invest resources and further improve our enforcement on this kind of content. Our hearts go out to those suffering from the tragic consequences of this epidemic — it requires all of us to work together to stop it.”

This post appeared first on NBC NEWS

previous post
‘Election interference’: Trump lawyers call for delayed sentencing in Bragg case
next post
True North Copper

You may also like

Tesla shares plunge 15%, steepest drop in five...

March 11, 2025

Starbucks CEO is out after just over a...

August 15, 2024

Tesla denies report that the EV maker is...

May 2, 2025

Tesla agrees to first deal to build China’s...

June 21, 2025

Companies are slashing prices to woo consumers. It’s...

July 28, 2024

Lucid CEO says Wall Street misinterpreted $1.75 billion...

October 23, 2024

Sierra Space CEO leaves as $5 billion company...

January 8, 2025

CrowdStrike losses may be biggest test yet of...

July 25, 2024

McDonald’s is the latest company to roll back...

January 8, 2025

E.l.f. Beauty to acquire Hailey Bieber skin care...

May 30, 2025

Recent Posts

  • Trump lashes out at Crockett, renews call for cognitive test
  • Trump goes after Zelenskyy over ‘land swapping’ dispute, lays out ‘feel out meeting’ with Putin
  • Democratic whistleblower told FBI that Adam Schiff approved classified leaks to target Trump
  • MORNING GLORY: Trump meets Putin amid an era done away with John Quincy Adams’ ‘abroad’
  • ‘Things need to change’: Senate Democrats sharpen criticism of Israel as humanitarian concerns grow

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (867)
    • Investing (2,729)
    • Politics (3,369)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 Sightful Invest. All Rights Reserved.